Trial
NCT03396471
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Hoosier Cancer Research Network
Collaborators
Merck Sharp & Dohme LLC
Condition
Carcinoma, Unspecified Site
Intervention
Pembrolizumab
Why stopped
Study failed to meet its interim analysis endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-18